Improving the Dysregulation of FoxO1 Activity Is a Potential Therapy for Alleviating Diabetic Kidney Disease
A substantial proportion of patients with diabetes will develop kidney disease. Diabetic kidney disease (DKD) is one of the most serious complications in diabetic patients and the leading cause of end-stage kidney disease worldwide. Although some mechanisms have been revealed to contribute to the un...
Saved in:
Main Authors: | Yan Wang (Author), Weichun He (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of FoxO1 in acne and effect of isotretinoin on FoxO1 expression
by: Parul Kamboj, et al.
Published: (2024) -
Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries
by: Bingbing Li, et al.
Published: (2023) -
Tanshinone IIA Alleviates Traumatic Brain Injury by Reducing Ischemia‒Reperfusion via the miR-124-5p/FoxO1 Axis
by: Wenbing Su, et al.
Published: (2024) -
Resveratrol Improves the Progression of Osteoarthritis by Regulating the SIRT1-FoxO1 Pathway-Mediated Cholesterol Metabolism
by: ChuanCai Liang, et al.
Published: (2023) -
Tetrandrine induces muscle atrophy involving ROS-mediated inhibition of Akt and FoxO3
by: Xin-qi Shan, et al.
Published: (2024)